Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation


Por: Cesaro, S, Pillon, M, Tridello, G, Aljurf, M, Martino, R, Schroyens, W, Nozzoli, C, Barba, P, Faraci, M, Fagioli, F, Cappelli, B, Cordonnier, C, Al-Mohareb, F, Floisand, Y, Greil, J, Panizzolo, IS, Santarone, S

Publicada: 1 jun 2013
Resumen:
To investigate the relationship between clinical response and modification of BK viremia, we assessed retrospectively 32 cases of hemorrhagic cystitis (HC) after allogeneic hematopoietic SCT that were treated with i.v. cidofovir (CDV). They were 22 men (69%) and 10 women (31%) with a median age of 24 years, range 3-62. The median number of CDV doses was 3, range 1-8, and the treatment lasted for a median of 3 weeks, range 1-10. Clinical improvement of HC was observed in 27 patients (84%). In 12 of 32 episodes (37.5%), BK viremia was determined before every CDV administration and a complete clinical response was observed in 10 of 12 patients (83%), the reduction of BK viremia load being >= 1 log by 2 weeks after starting CDV. Nephrotoxicity related to CDV was observed in nine patients. Among 26 patients with 100-day follow-up, 4 of 4 patients who had a complete clinical response by 30 days were alive vs 16 of 22 (73%) who did not have the resolution of HC in this time frame. We conclude that in patients with HC, the response to CDV treatment is usually associated with a significant reduction of BK viremia load.

Filiaciones:
Cesaro, S:
 Azienda Osped Univ Integrata, I-1037134 Verona, Italy

Pillon, M:
 Univ Padua, Dept Pediat, Padua, Italy

Tridello, G:
 Azienda Osped Univ Integrata, I-1037134 Verona, Italy

Aljurf, M:
 King Faisal Specialist Hosp & Res Ctr, Adult HSCT Program, Riyadh 11211, Saudi Arabia

Martino, R:
 Hosp Santa Creu & Sant Pau, Clin Hematol Div, Barcelona, Spain

Schroyens, W:
 Antwerp Univ Hosp UZA, Dept Hematol, Antwerp, Belgium

Nozzoli, C:
 Osped Careggi, Dept Hematol, BMT Unit, Florence, Italy

Barba, P:
 Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain

Faraci, M:
 Inst G Gaslini, Dept Hematol, Genoa, Italy

Fagioli, F:
 Osped Infantile Regina Margherita, Turin, Italy

Cappelli, B:
 Ist Sci San Raffaele, I-20132 Milan, Italy

Cordonnier, C:
 Henri Mondor Univ Hosp, Dept Hematol, Creteil, France

Al-Mohareb, F:
 King Faisal Specialist Hosp & Res Ctr, Adult HSCT Program, Riyadh 11211, Saudi Arabia

Floisand, Y:
 Univ Oslo, Rikshosp, Dept Med, N-0027 Oslo, Norway

Greil, J:
 Heidelberg Univ, Clin Hematol Div, Heidelberg, Germany

Panizzolo, IS:
 Azienda Osped Univ Integrata, I-1037134 Verona, Italy

Santarone, S:
 Osped Civile, Dept Hematol, Pescara, Italy
ISSN: 02683369





BONE MARROW TRANSPLANTATION
Editorial
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, GB
Tipo de documento: Article
Volumen: 48 Número: 6
Páginas: 809-813
WOS Id: 000319967200011
ID de PubMed: 23222380
imagen Bronze

MÉTRICAS